SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000908834-23-000146
Filing Date
2023-11-09
Accepted
2023-11-09 17:18:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 agio_13g.htm SC 13G 443318
  Complete submission text file 0000908834-23-000146.txt   445074
Mailing Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111
Business Address C/O FARALLON PARTNERS, L.L.C. ONE MARITIME PLAZA, SUITE 2100 SAN FRANCISCO CA 94111 (415) 421-2132
Farallon Capital Partners, L.P. (Filed by) CIK: 0001175707 (see all company filings)

IRS No.: 943106322 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Subject) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87570 | Film No.: 231393799
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences